The Market at 25th to raise awareness on Multiple Myeloma [unable to retrieve full-text content] Multiple Myeloma is a cancer of the plasma cells beginning in the bone marrow. The partnership will be raising awareness for the rest of the month of …Published at Wed, 10 Mar 2021 18:33:45 +0000
Read More
Facts About Prostate Cancer That Spread to Bones When prostate cancer spreads, the bones are typically the first area affected. Bone metastases can weaken your bones and lead to symptoms like bone pain. There’s no cure for metastatic bone cancer, but treatment options may help alleviate symptoms to keep you comfortable. Prostate cancer is one […]
Read More
New lung cancer screening guidelines double the number of smokers eligible for annual scans More Americans now qualify for yearly scans to detect lung cancer, according to guidelines released Tuesday that may help more Black smokers and women get screened. Lung cancer is the nation’s top cancer killer, causing more than 135,000 deaths each year. […]
Read More
Yearly Lung Cancer Scans Are Advised for People 50 and Over With Shorter Smoking Histories New advice from an influential panel will make more women and African-Americans eligible for CT scans, but some who need them most may not be able to afford them. New guidelines from medical experts will nearly double the number of […]
Read More
Cyclin-dependent Kinase Inhibitor Market 2021 | Extensive Market Growth | Opportunities | Impact … A complete report on Cyclin-dependent Kinase Inhibitor Market was published by The Data Bridge Market Research to understand the comprehensive setup of Cyclin-dependent Kinase Inhibitor Market industries. Cyclin-dependent Kinase Inhibitor market research report provides professional and broad market report primary and […]
Read More
Is it Time to Dump XTL Biopharmaceuticals Ltd (XTLB) Stock After it Has Gained 3.42% in a Week? Overall market sentiment has been down on X T L Biopharmaceuticals Ltd (XTLB) stock lately. XTLB receives a Bearish rating from InvestorsObserver’s Stock Sentiment Indicator. X T L Biopharmaceuticals Ltd has a Bearish sentiment reading. Find out […]
Read More
Multiple Myeloma CAR T-Cell Therapy Achieves Response in 73% Patients Multiple Myeloma CAR T-Cell Therapy Achieves Response in 73% of Patients clinicalomicsprowebdirectory Scroll Up MORE CONTENT We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our […]
Read More
Smoldering multiple myeloma: Early detection and intervention approaches by Dr. Mark Bustoros Mark Bustoros, MD provides an update on the research of early detection of multiple myeloma and intervention approaches that have the potential to greatly improve outcomes for multiple myeloma patients.
Read More
PLEIADES: Daratumumab combinations for multiple myeloma Dr Ajai Chari talks to ecancer at the International Myeloma Workshop 2019 about the PLEIADES studies. The studies look at daratumumab in combination with a variety of standard multiple myeloma treatment regimens. Dr Chari outlines some of the data from this trial, as well as any toxicities. Sign up […]
Read More
Steba Biotech receives FDA Orphan Drug Designation for Padeliporfin ImPACT in Upper Tract … Designation confers advantages including marketing exclusivity and tax credits Padeliporfin ImPACT pivotal Phase 3 trial in UTUC to start end Q1 2021 LUXEMBOURG, March 08, 2021 (GLOBE NEWSWIRE) — Steba Biotech, the IMmune Photo Activate Cancer Treatment (IMPACT) specialist today announces the […]
Read More